Use of dapsone in chronic/refractory immune thrombocytopenic patients: A single center experience
Background: Dapsone is a second-line therapy for immune thrombocytopenia (ITP). It is cost-effective, with a response rate comparable to other drugs used as second-line therapy, such as azathioprine, danazol, cyclophosphamide, cyclosporine, vincristine, rituximab, and eltrombopag.Material and Method...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nizameddin KOCA
2023-04-01
|
| Serija: | Turkish Journal of Internal Medicine |
| Online pristup: | https://dergipark.org.tr/en/download/article-file/2800540 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|